Completed EARLY_PHASE1 INTERVENTIONAL 1-arm NCT03979898

Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP (CP)

Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Cerebral Palsy (CP)

Sponsor: Kyung Hee University Hospital at Gangdong

Conditions Cerebral Palsy

Interventions ASTROSTEM

Updated 5 times since 2019 Last updated: Jun 6, 2019 Started: Jun 15, 2017 Primary completion: Apr 23, 2019 Completion: May 13, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03979898, this EARLY_PHASE1 trial focuses on Cerebral Palsy and remains completed. Sponsored by Kyung Hee University Hospital at Gangdong, it has been updated 5 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed EARLY_PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jul 2019 — Jan 2021 [monthly]

Completed EARLY_PHASE1

First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kyung Hee University Hospital at Gangdong
R-Bio

Data source: R-Bio

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea